SCHEMBL24906196

SCHEMBL24906196

COC(=O)c1c(I)c(OCc2ccccc2)nn1COCC[Si](C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 3/20 0.41
LMNA P02545 1/20 0.38
HPGD P15428 1/20 0.38
PKM P14618 1/20 0.36
CNR1 P21554 2/20 0.36
ACHE P22303 1/20 0.36
CNR2 P34972 1/20 0.36
HTR2A P28223 1/20 0.35
HTR2C P28335 1/20 0.35
SLC6A4 P31645 1/20 0.35
F11 P03951 1/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
USP2 O75604 1/20 0.34
ALDH1A1 P00352 1/20 0.34
TSHR P16473 1/20 0.34
HSD17B10 Q99714 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
GABRA1 P14867 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24906198 0.86 DGAT1 (0.39) DGAT1LMNAHPGDPKMCNR1
SCHEMBL21713009 0.77 ALDH1A1 (0.34) DGAT1KMT2AALDH1A1
SCHEMBL22900570 0.72 DGAT1 (0.35) DGAT1HPGDKMT2AALDH1A1HSD17B10
SCHEMBL16517390 0.72 MAP2K1 (0.39) DGAT1HPGDSMN1; SMN2ALDH1A1TSHR
SCHEMBL17782696 0.71 DGAT1 (0.43) DGAT1HPGDMEN1KMT2AALDH1A1
SCHEMBL14605115 0.70 TDP1 (0.43) LMNAHPGDCNR1SMN1; SMN2ALDH1A1
SCHEMBL21987968 0.69 DGAT1 (0.44) DGAT1LMNAF11SMN1; SMN2ALDH1A1
SCHEMBL732954 0.69 DGAT1 (0.43) DGAT1LMNAHPGDMEN1KMT2A
SCHEMBL23294652 0.69 MAPT (0.36) DGAT1MEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL29749458 0.69 NPSR1 (0.33) DGAT1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4634159-A1 SULFOXIMINES AS INHIBITORS OF NAV1.8 Grünenthal GmbH (DE) 2025-10-22 EP disclosed
US-20240252473-A1 Sulfoximines as inhibitors of NaV1.8 GRUENENTHAL GMBH (DE) 2024-08-01 US disclosed
WO-2024126648-A1 SULFOXIMINES AS INHIBITORS OF NaV1.8 Grünenthal GmbH (DE) 2024-06-20 WO disclosed
US-11999699-B2 Substituted pyrazole amides Grünenthal GmbH (DE) 2024-06-04 US disclosed
EP-4355733-A1 SUBSTITUTED PYRAZOLE AMIDES Grünenthal GmbH (DE) 2024-04-24 EP disclosed
US-20230025025-A1 SUBSTITUTED PYRAZOLE AMIDES GRUENENTHAL GMBH (DE) 2023-01-26 US disclosed
US-20230025025-A1 SUBSTITUTED PYRAZOLE AMIDES GRUENENTHAL GMBH (DE) 2023-01-26 US disclosed
WO-2022263498-A1 SUBSTITUTED PYRAZOLE AMIDES Grünenthal GmbH (DE) 2022-12-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11999699-B2 Substituted pyrazole amides SCN8A, SCN1A, SCN7A DGAT1 2559/4885LMNA 2843/4885HPGD 977/4885
US-20240252473-A1 Sulfoximines as inhibitors of NaV1.8 SCN8A, SCN10A, SCN7A DGAT1 3043/4885LMNA 3870/4885HPGD 1231/4885
US-20230025025-A1 SUBSTITUTED PYRAZOLE AMIDES SCN8A, SCN1A, SCN7A DGAT1 2559/4885LMNA 2843/4885HPGD 977/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.